Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

210 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The modified Baveno classification for obstructive sleep apnoea - Development and evaluation based on the ESADA database.
Matthes S, Treml M, Grote L, Hedner J, Zou D, Bonsignore MR, Pépin JL, Bailly S, Ryan S, McNicholas WT, Schiza SE, Verbraecken J, Pataka A, Śliwiński P, Basoglu ÖK, Lombardi C, Parati G, Randerath WJ; ESADA collaborators. Matthes S, et al. Among authors: verbraecken j. Eur Respir J. 2024 Oct 31:2401371. doi: 10.1183/13993003.01371-2024. Online ahead of print. Eur Respir J. 2024. PMID: 39481866
Sleep apnoea phenotypes in women: A cluster analysis from the ESADA cohort.
Pataka A, Pepin JL, Bonsignore MR, Schiza S, Saaresranta T, Bouloukaki I, Steiropoulos P, Trakada G, Riha R, Dogas Z, Testelmans D, Basoglu OK, Mihaicuta S, Fanfulla F, Grote L, Bailly S; ESADA Study Group. Pataka A, et al. Sleep Med. 2024 Oct 15;124:494-501. doi: 10.1016/j.sleep.2024.10.015. Online ahead of print. Sleep Med. 2024. PMID: 39437459
Pitolisant 40 mg for excessive daytime sleepiness in obstructive sleep apnea patients treated or not by CPAP: Randomised phase 3 study.
Dauvilliers Y, Craig SE, Bonsignore MR, Barbé F, Verbraecken J, Asin J, Georgiev O, Tiholov R, Caussé C, Lecomte JM, Schwartz JC, Lehert P, Randerath W, Pépin JL; HAROSA III Study Group. Dauvilliers Y, et al. Among authors: verbraecken j. J Sleep Res. 2024 Oct 8:e14373. doi: 10.1111/jsr.14373. Online ahead of print. J Sleep Res. 2024. PMID: 39377364
Comparative efficacy, safety and benefit/risk of alerting agents for excessive daytime sleepiness in patients with obstructive sleep apnoea: a network meta-analysis.
Pépin JL, Lehert P, Ben Messaoud R, Joyeux-Faure M, Caussé C, Asin J, Barbé F, Bonsignore MR, Randerath W, Verbraecken J, Craig S, Dauvilliers Y. Pépin JL, et al. Among authors: verbraecken j. EClinicalMedicine. 2024 Sep 19;76:102843. doi: 10.1016/j.eclinm.2024.102843. eCollection 2024 Oct. EClinicalMedicine. 2024. PMID: 39346006 Free PMC article.
Personalized Treatment for Obstructive Sleep Apnea: Beyond CPAP.
Van Daele M, Smolders Y, Van Loo D, Bultynck C, Verbraecken J, Vroegop A, Lapperre T, Op de Beeck S, Dieltjens M, Vanderveken OM. Van Daele M, et al. Among authors: verbraecken j. Life (Basel). 2024 Aug 13;14(8):1007. doi: 10.3390/life14081007. Life (Basel). 2024. PMID: 39202749 Free PMC article.
210 results